Anti-ulcer drug
 ;templatestyles src="Infobox drug/styles.css"/ ;
Trecadrine (INNTooltip International Nonproprietary Name) is a drug that was originally developed as an anti-ulcer agent but was found to act as a β3-adrenergic receptor agonist with potential anti-obesity and anti-diabetic properties. It is selective for the β3-adrenergic receptor, lacking activity at the β1- and β2-adrenergic receptors. The drug is orally active. Structurally, trecadrine is a substituted β-hydroxyamphetamine and derivative of β-hydroxy-"N"-methylamphetamine (ephedrine, pseudoephedrine) with a tricyclic moiety attached at the amine.
References.
 ;templatestyles src="Reflist/styles.css" / ;